share_log

Eiger BioPharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Moshe Arkin(10.09%)

SEC announcement ·  Nov 24, 2023 06:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more